Trials / Completed
CompletedNCT06727019
Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- Beijing Tongren Hospital · Academic / Other
- Sex
- All
- Age
- 7 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
To compare the preventive effects of daily low-level red-light and 0.01% low-dose atropine eye drops on myopia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | low-level red-light | 650-nm low-level red-light |
| DRUG | Atropine (0.01%) | Atropine eye drops at concentration of 0.01% |
Timeline
- Start date
- 2023-04-10
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
- First posted
- 2024-12-10
- Last updated
- 2024-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06727019. Inclusion in this directory is not an endorsement.